"eStudySite San Diego operates two dedicated clinical research sites in La Mesa, CA and Chula Vista, CA. We have a worldwide leadership reputation for excellence in conducting clinical trials spanning antibiotics, antivirals, vaccines, diagnostics, and devices. We also have a thriving San Diego research study practices encompassing a broad range of therapeutic areas including acute infections, chronic diseases, women's health, orphan diseases, endocrinology, hepatology, dermatology, gastroenterology, and other therapeutic areas. Learn more about what we have to offer patients looking to enroll and support drug trials in San Diego!"

During the past decade, eStudySite conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 17 clinical trials were completed, i.e. on average, 68% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 14 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "eStudySite" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored and "Phathom Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "eStudySite" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Accelovance" with 1 trials as a collaborator and "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "eStudySite" are "Nonalcoholic Steatohepatitis" (4 trials), "Osteoarthritis" (3 trials), "Heartburn" (2 trials), "Non-Erosive Gastro-Esophageal Reflux Disease" (2 trials) and "Acne Vulgaris" (1 trials). Many other conditions were trialed in "eStudySite" in a lesser frequency.

Most popular intervention types in "eStudySite" are "Drug" (24 trials), "Biological" (11 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "SEL" (2 trials), "Vonoprazan" (2 trials), "placebo" (2 trials) and "tanezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "eStudySite" are 31 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "eStudySite". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in eStudySite, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in eStudySite, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".